Table 2.

Current randomized trials of trabectedin in sarcomas.^*

Phase	Arms	Setting	Sponsor	NCT #	Endpoint
II	Doxorubicin ± trabectedin	1st line STS	Spain	01104298	PFS
II/III	Doxorubicin vs. trabectedin	1st line STS	EORTC	01189253	PFS
III	Doxorubicin ± IFF vs. trabectedin	TRS**	J and J	00796120	PFS
III	DTIC vs. trabectedin	LMS/LPS	J and J	Pending	OS

Notes:

^*ClinicalTrials.gov;

^**Translocation-related sarcoma.